✦ LIBER ✦

Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study

✍ Scribed by Hanna, Nasser; Ansari, Rafat; Fisher, William; Shen, Jianzhao; Jung, Sin-Ho; Sandler, Alan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

266 A phase II study of VP-16 plus ifosf

✍ Sandler, A.B.; Ansari, R.; Fisher, W.; Gonin, R.; Levy, R.; Einhorn, L.H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase II study of daily oral etoposide p

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 266 KB

A phase III study of VP16 plus cisplatin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P-774 Phase II study of cisplatin plus e

✍ Kashii, T.; Saito, H.; Negoro, S.; Takada, Y.; Ichinose, Y.; Matsui, K.; Eguchi, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Etoposide plus cisplatin followed by con

✍ Xenidis, N.; Kotsakis, A.; Kalykaki, A.; Christophyllakis, Ch.; Giassas, S.; Ken 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 141 KB

P-62 Phase II trial of irinotecan plus c

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB